In last trading session, ATAI Life Sciences N.V (NASDAQ:ATAI) saw 2.06 million shares changing hands with its beta currently measuring 1.46. Company’s recent per share price level of $2.2 trading at $0.09 or 4.27% at ring of the bell on the day assigns it a market valuation of $441.66M. That closing price of ATAI’s stock is at a discount of -20.0% from its 52-week high price of $2.64 and is indicating a premium of 53.18% from its 52-week low price of $1.03.
For ATAI Life Sciences N.V (ATAI), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
ATAI Life Sciences N.V (NASDAQ:ATAI) trade information
Upright in the green during last session for gaining 4.27%, in the last five days ATAI remained trading in the red while hitting it’s week-highest on Friday, 06/20/25 when the stock touched $2.2 price level, adding 12.35% to its value on the day. ATAI Life Sciences N.V’s shares saw a change of 64.18% in year-to-date performance and have moved -0.90% in past 5-day. ATAI Life Sciences N.V (NASDAQ:ATAI) showed a performance of 6.80% in past 30-days.
Wall Street analysts have assigned a consensus price target of 5 to the stock, which implies a rise of 56.0% to its current value. Analysts have been projecting 5 as a low price target for the stock while placing it at a high target of 5. It follows that stock’s current price would drop -127.27% in reaching the projected high whereas dropping to the targeted low would mean a loss of -127.27% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 18.62% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 44.55% while estimates for its earnings growth in next 5 years are of 32.82%.
ATAI Life Sciences N.V (NASDAQ:ATAI)’s Major holders
WALLEYE CAPITAL LLC is the top institutional holder at ATAI for having 2.76 million shares of worth $3.67 million. And as of 2024-06-30, it was holding 1.7226 of the company’s outstanding shares.
The second largest institutional holder is MORGAN STANLEY, which was holding about 2.72 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.6952 of outstanding shares, having a total worth of $3.62 million.
